# Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old

> **NCT01355172** · PHASE4 · COMPLETED · sponsor: **Adimmune Corporation** · enrollment: 59 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** AdimFlu-S

## Key facts

- **NCT ID:** NCT01355172
- **Lead sponsor:** Adimmune Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11
- **Primary completion:** 2011-09
- **Final completion:** —
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2012-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355172, "Immunogenicity and Safety of AdimFlu-S, Formulation 2010-2011, in Infants Aged Between 6-12months Old". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01355172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*